Factors Associated with Drug Consumption Without Scientific Evidence in Patients with Mild COVID-19 in Peru
- David R. Soriano-Moreno,
- ,
- Lucero Sangster-Carrasco,
- Carlos Quispe-Vicuña,
- Pamela Grados-Espinoza,
- Fabricio Ccami-Bernal
- Universidad Peruana Union,
- ,
- Universidad Peruana de Ciencias Aplicadas,
- Sociedad Científica San Fernando UNMSM (SCSF-UNMSM),
- Universidad Nacional Daniel Alcides Carrión,
- Facultad de Medicina de la Universidad Nacional de San Agustín
Open access
Publication Information
Output type
Original language
EnglishPages from-to (Number of pages)
Pages E1189-E1195Journal (Volume, Issue Number)
Journal of patient safety (Volume 18, Issue 8)Publication milestones
- Published - 01/12/2022
Publication status
ISSN
1549-8417Publication IDs
- Scopus: 85143379850
- PubMed: 35858482
Abstract
Objective This study aimed to evaluate the factors associated with the consumption of drugs without scientific evidence in patients with mild COVID-19 infection in Peru. Methods An analytical cross-sectional study was carried out including 372 adult patients with a history of mild COVID-19 disease. Factors associated with drug consumption were evaluated by Poisson regressions with robust variance adjustment using the bootstrapping resampling method. Results Seventy-two percent consumed some medication without scientific evidence, with antibiotics (71%) and ivermectin for human use (68%) being the most commonly used. Factors associated with the consumption of drugs to treat mild COVID-19 infection were thinking that the drugs are not effective (adjusted prevalence ratio, 0.55; 95% confidence interval, 0.41-0.74) and not being informed about the efficacy of the drugs (adjusted prevalence ratio, 0.48; 95% confidence interval, 0.36-0.65). Conclusions Education of the population seems to be the main factor that increases the consumption of drugs without scientific evidence in the Peruvian population to treat mild COVID-19.
Publication metrics
Metrics
PlumX, opens in new tab
Sustainable Development Goals
- SDG 3 Good Health and Well
